scholarly journals Rectosigmoid colon cancer

2021 ◽  
Author(s):  
Mohammad Niknejad
2013 ◽  
Vol 12 (2) ◽  
pp. 103-105
Author(s):  
M. H. Hnatiuk ◽  
Yu. P. Petruk ◽  
M. V. Lianskorunskyi ◽  
S. I. Raichuk ◽  
S. Yu. Shevchenko ◽  
...  

2012 ◽  
Vol 27 (9) ◽  
pp. 1215-1222 ◽  
Author(s):  
Satoshi Ogiso ◽  
Takashi Yamaguchi ◽  
Meiki Fukuda ◽  
Takahide Murakami ◽  
Yoshihisa Okuchi ◽  
...  

2015 ◽  
Vol 81 (12) ◽  
pp. 1232-1236 ◽  
Author(s):  
Masashi Yamamoto ◽  
Keitaro Tanaka ◽  
Mitsuhiro Asakuma ◽  
Keisaku Kondo ◽  
Masatsugu Isii ◽  
...  

Laparoscopic surgery is widespread and is safe and effective for the management of patients with colorectal cancer. However, surgical site infection (SSI) remains an unresolved complication. The present study investigated the comparative effect of supraumbilical incision versus transumbilical incision (TU) on the incidence of SSI in patients undergoing laparoscopic surgery for colon cancer. Medical records from patients with colorectal cancer who underwent laparoscopic sigmoid and rectosigmoid colon surgeries with either supraumbilical incision (n = 150) or TU (n = 150) were retrospectively reviewed. There was no difference in demographics, comorbidities, or operative variables between the two groups. The transumbilical group and the supraumbilical group were comparable with regards to overall SSI (6.0% vs 4.0%; P = 0.4062), superficial SSI (6.0% vs 3.3%; P = 0.2704), and deep SSI (0% vs 0.7%; P = 0.2385). SSI developed after laparoscopic sigmoid and rectosigmoid colon cancer surgery in 15 (5.0%) of the 300 patients. Of these superficial SSI, all wounds were in the left lower quadrant incision, and the transumbilical port sites did not become infected. Univariate analysis failed to identify any risk factors for SSI. Avoidance of the umbilicus offers no benefit with regard to SSI compared with TU.


2014 ◽  
Vol 31 (6) ◽  
pp. 452-458 ◽  
Author(s):  
Masashi Yamamoto ◽  
Junji Okuda ◽  
Keitaro Tanaka ◽  
Masatsugu Ishii ◽  
Hiroki Hamamoto ◽  
...  

2014 ◽  
Vol 7 (4) ◽  
pp. 317-319 ◽  
Author(s):  
Yoshiaki Maeda ◽  
Toshiki Shinohara ◽  
Akihisa Nagatsu ◽  
Noriaki Futakawa ◽  
Tomonori Hamada

2016 ◽  
Vol 85 (5) ◽  
pp. 1020-1026
Author(s):  
Seonji Jeong ◽  
Se Hyung Kim ◽  
Ijin Joo ◽  
Su Joa Ahn ◽  
Joon Koo Han

2019 ◽  
Vol 97 (2) ◽  
pp. 74 ◽  
Author(s):  
Gyung Mo Son ◽  
Tae Un Kim ◽  
Byung-Soo Park ◽  
Hyuk Jae Jung ◽  
Sang Su Lee ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Ji Hoon Choi ◽  
Jung A. Shin ◽  
Hye Kyeong Park ◽  
Su Young Kim ◽  
Hoon Jung ◽  
...  

Acute lung injury occasionally occurs after chemotherapy, but pulmonary toxicities by oxaliplatin-based chemotherapy have rarely been identified. A 76-year-old female with rectosigmoid colon cancer presented with ongoing dyspnea after the eighth cycle of standard chemotherapy (5-fluorouracil, sodium folinic acid, and oxaliplatin: FOLFOX). Nodular consolidation progressed despite antibiotics and BAL fluid analysis was compatible with the diagnosis of sarcoidosis. Corticosteroid therapy rapidly improved the symptoms and radiographic findings. We report this first case of secondary sarcoidosis related to FOLFOX therapy with review of references.


Sign in / Sign up

Export Citation Format

Share Document